13F reference period
Q3 2026
CUSIP: 02081G102
13F reference period
Q3 2026
Institutions Reporting
1
Shares (Excl. Options)
Price
$9.90
The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 1 institution filings for Q3 2026.
Security key
02081G102
13F reference period
Q3 2026
13F holders
1
13D/G owners
2
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 02081G102:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| L-5 Healthcare Partners, LLC | 5% | -6.8% | 7,201,158 | -6.5% | L-5 Healthcare Partners, LLC | 23 Apr 2025 | ||
| Gen IV Investment Opportunities, LLC | 14% | 3,494,258 | GEN IV INVESTMENT OPPORTUNITIES, LLC | 07 Aug 2026 |
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 600 | $5,940 | +$5,940 | $9.90 | 1 |
| 2016 Q4 | 60,033 | $193,000 | -$1,045,659 | $3.21 | 1 |
| 2016 Q3 | 385,287 | $3,622,000 | -$45,722,047 | $9.40 | 1 |
| 2016 Q2 | 21,415,075 | $7,499,000 | -$177,004 | $0.35 | 31 |
| 2016 Q1 | 22,308,953 | $5,354,000 | -$683,173 | $0.24 | 33 |
| 2015 Q4 | 24,935,754 | $7,479,000 | -$1,989,199 | $0.30 | 45 |
| 2015 Q3 | 24,905,671 | $8,214,000 | -$3,155,089 | $0.33 | 44 |
| 2015 Q2 | 29,866,663 | $41,212,000 | +$385,613 | $1.38 | 48 |
| 2015 Q1 | 29,569,826 | $42,849,000 | +$2,103,361 | $1.45 | 48 |
| 2014 Q4 | 28,148,144 | $39,671,000 | +$4,348,433 | $1.41 | 54 |
| 2014 Q3 | 25,031,807 | $42,388,000 | -$1,879,441 | $1.70 | 57 |
| 2014 Q2 | 24,936,882 | $40,622,535 | -$4,532,784 | $1.63 | 70 |
| 2014 Q1 | 27,833,945 | $41,702,193 | -$10,412,649 | $1.50 | 74 |